The history of Sildenafil presents a complex picture for shareholders. While the initial release generated substantial returns, the expiration of its patent opened the door to off-brand alternatives, dramatically https://carlyltzg577371.bloggin-ads.com/64967570/sildenafil-and-big-pharma-a-volatile-bet